THE ROYAL MARSDEN CANCER CHARITY

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -18%

  £456,000 → £374,000

• Cash

  +91.7%

  £1,996,000 → £3,827,000

• Net assets

  +3.3%

  £126,039,000 → £130,186,000

• Employees

  +18.8%

  85 → 101

• Wages

  +20.4%

  £3,793,000 → £4,565,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

1. THE ROYAL MARSDEN CANCER CHARITY 2010-09-09 → present
2. ROYAL MARSDEN CANCER CAMPAIGN 2002-12-12 → 2010-09-09

Accounting basis

FRS 102

Reporting scope

Consolidated group

Auditor

Buzzacott Audit LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.”

Group structure

1. THE ROYAL MARSDEN CANCER CHARITY · parent
   1. Royal Marsden Cancer Campaign Trading Company Limited 100% · England and Wales · non-primary purpose trading activities

Significant events

• “The announcement in January 2025 that Their Royal Highnesses The Prince and Princess of Wales had become Joint Patrons of The Royal Marsden NHS Foundation Trust.”
• “Tokio Marine Kiln and its staff collectively raised and donated over £220,000 in 2024/25.”
• “Celebrated 10 years of the Father and Son Day campaign in June 2024.”
• “The second series of 'Super Surgeons: A Chance at Life' aired on Channel 4 in June and July 2024.”
• “The Symani® Surgical System was successfully installed at The Royal Marsden, Chelsea in October 2024, with the first reconstruction procedure carried out in November 2024.”
• “A new, dual source Computerised Tomography (CT) scanner was installed this year (2024/25).”
• “A state-of-the-art binding site EXENT analyser was installed in December 2024 to enable more accurate and personalised disease monitoring.”
• “In March 2025, the Board of Trustees agreed to appoint Goldman Sachs Asset Management as the Outsourced Chief Investment Officer, with transition in 2025/26.”
• “On 3 June 2025, the Charity completed the purchase of a property which will be rented to The Royal Marsden NHS Foundation Trust.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

7

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.